Peritoneal mesothelium promotes the progression of ovarian cancer cells in vitro and in a mice xenograft model in vivo

Cancer Lett. 2014 Dec 28;355(2):310-5. doi: 10.1016/j.canlet.2014.09.041. Epub 2014 Oct 6.

Abstract

The role of mesothelial cells in the intraperitoneal spread of ovarian cancer is still elusive. In particular, it is unclear whether these cells constitute a passive barrier preventing cancer cell progression or perhaps act as an active promoter of this process. In this report we show that omental human peritoneal mesothelial cells (HPMCs) stimulate adhesion and proliferation of ovarian cancer cells (A2780, OVCAR-3, SKOV-3). The latter was associated with the paracrine activity of GRO-1, IL-6, and IL-8 released to the environment by HPMCs. Furthermore, the growth dynamics of ovarian cancer xenografts produced in response to i.p. injection of ovarian cancer cells together with HPMCs was remarkably greater than for implantation of cancer cells alone. A layer of peritoneal mesothelium was consistently present in close proximity to the tumor mass in every xenograft model. In conclusion, our results indicate that HPMCs play a supporting role in the intraperitoneal invasiveness of ovarian malignancy, whose effect may be attributed to their ability to stimulate adhesion and proliferation of cancer cells.

Keywords: Mice xenografts; Ovarian cancer metastasis; Peritoneal mesothelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Adhesion / physiology
  • Cell Line, Tumor
  • Cell Proliferation / physiology
  • Chemokine CXCL1 / metabolism
  • Disease Progression
  • Epithelium / metabolism
  • Epithelium / pathology*
  • Female
  • Heterografts
  • Humans
  • Interleukin-6 / metabolism
  • Interleukin-8 / metabolism
  • Mice
  • Ovarian Neoplasms / metabolism
  • Ovarian Neoplasms / pathology*
  • Peritoneum / metabolism
  • Peritoneum / pathology*

Substances

  • CXCL1 protein, human
  • Chemokine CXCL1
  • Interleukin-6
  • Interleukin-8